Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 3 de 3
Filtrer
Plus de filtres











Gamme d'année
1.
Clinics (Sao Paulo) ; 76: e3222, 2021.
Article de Anglais | MEDLINE | ID: mdl-34852139

RÉSUMÉ

The current study found that high Zeste White 10 interactor (ZWINT) expression is related to the poor prognosis of patients with a variety of cancers. This study mainly explored the relationship between the expression level of ZWINT and the prognosis of patients with lung adenocarcinoma (LUAD). Briefly, four English databases and two high-throughput sequencing databases were searched and relevant data for meta-analysis were extracted. Pooled mean difference and 95% confidence interval (CI) were used to assess the relationships between clinical features and the expression of ZWINT. Pooled hazard ratio and 95% CI were also used to assess the relationships between clinical features and the expression level of ZWINT. This meta-analysis was registered in PROSPERO (CRD42021249475). A total of 16 high-quality datasets comprising 2,847 LUAD patients were included in this study. Higher ZWINT expression levels were found in patients younger than 65 years, males, and smokers, and were correlated with advanced TNM stages and poor prognosis. Notably, there was no publication bias in this meta-analysis. Overall, our findings indicate that ZWINT is a potential biomarker for poor prognosis and clinicopathological outcomes of patients with LUAD.


Sujet(s)
Adénocarcinome pulmonaire , Tumeurs du poumon , Adénocarcinome pulmonaire/génétique , Adénocarcinome pulmonaire/anatomopathologie , Marqueurs biologiques tumoraux/analyse , Humains , Protéines et peptides de signalisation intracellulaire , Tumeurs du poumon/génétique , Tumeurs du poumon/anatomopathologie , Mâle , Protéines nucléaires , Pronostic , Modèles des risques proportionnels
2.
Clinics ; Clinics;76: e3222, 2021. tab, graf
Article de Anglais | LILACS | ID: biblio-1350627

RÉSUMÉ

The current study found that high Zeste White 10 interactor (ZWINT) expression is related to the poor prognosis of patients with a variety of cancers. This study mainly explored the relationship between the expression level of ZWINT and the prognosis of patients with lung adenocarcinoma (LUAD). Briefly, four English databases and two high-throughput sequencing databases were searched and relevant data for meta-analysis were extracted. Pooled mean difference and 95% confidence interval (CI) were used to assess the relationships between clinical features and the expression of ZWINT. Pooled hazard ratio and 95% CI were also used to assess the relationships between clinical features and the expression level of ZWINT. This meta-analysis was registered in PROSPERO (CRD42021249475). A total of 16 high-quality datasets comprising 2,847 LUAD patients were included in this study. Higher ZWINT expression levels were found in patients younger than 65 years, males, and smokers, and were correlated with advanced TNM stages and poor prognosis. Notably, there was no publication bias in this meta-analysis. Overall, our findings indicate that ZWINT is a potential biomarker for poor prognosis and clinicopathological outcomes of patients with LUAD.


Sujet(s)
Humains , Mâle , Adénocarcinome pulmonaire/génétique , Adénocarcinome pulmonaire/anatomopathologie , Tumeurs du poumon/génétique , Tumeurs du poumon/anatomopathologie , Pronostic , Protéines nucléaires , Marqueurs biologiques tumoraux/analyse , Modèles des risques proportionnels , Protéines et peptides de signalisation intracellulaire
3.
BMJ Open ; 10(7): e036452, 2020 07 12.
Article de Anglais | MEDLINE | ID: mdl-32660950

RÉSUMÉ

OBJECTIVE: This study aimed to evaluate the duration of intensive care unit (ICU) stay prior to onset of invasive candidiasis (IC)/candidaemia. DESIGN: Systematic review and meta-analysis. DATA SOURCES: PubMed, Cochrane, Embase and Web of Science databases were searched through June 2019 to identify relevant studies. ELIGIBILITY CRITERIA: Adult patients who had been admitted to the ICU and developed an IC infection. DATA EXTRACTION AND SYNTHESIS: The following data were extracted from each article: length of hospital stay, length of ICU stay, duration of ICU admission prior to candidaemia onset, percentage of patients who received antibiotics and duration of their antibiotic therapy prior to candidaemia onset, and overall mortality. In addition to the traditional meta-analyses, meta-regression was performed to explore possible mediators which might have contributed to the heterogeneity. RESULTS: The mean age of patients ranged from 28 to 76 years across selected studies. The pooled mean duration of ICU admission before onset of candidaemia was 12.9 days (95% CI 11.7 to 14.2). The pooled mean duration of hospital stay was 36.3±5.3 days (95% CI 25.8 to 46.7), and the pooled mean mortality rate was 49.3%±2.2% (95% CI 45.0% to 53.5%). There was no significant difference in duration of hospital stay (p=0.528) or overall mortality (p=0.111), but a significant difference was observed in the mean length of ICU stay (2.8 days, p<0.001), between patients with and without Candida albicans. Meta-regression analysis found that South American patients had longer duration of ICU admission prior to candidaemia onset than patients elsewhere, while those in Asia had the shortest duration. CONCLUSIONS: Patients with IC are associated with longer ICU stay, with the shortest duration of ICU admission prior to the candidaemia onset in Asia. This shows a more proactive strategy in the diagnosis of IC should be considered in caring for ICU patients.


Sujet(s)
Candidémie/épidémiologie , Durée du séjour , Antibactériens/usage thérapeutique , Australie/épidémiologie , Candidémie/microbiologie , Candidémie/mortalité , Chine/épidémiologie , Europe/épidémiologie , Humains , Unités de soins intensifs , Amérique du Nord/épidémiologie , Facteurs de risque , Amérique du Sud/épidémiologie , Taux de survie , Facteurs temps
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE